Provided by Tiger Fintech (Singapore) Pte. Ltd.

GT Biopharma Inc.

2.82
-0.0200-0.70%
Post-market: 2.880.0600+2.13%16:21 EDT
Volume:57.55K
Turnover:162.85K
Market Cap:8.88M
PE:-0.52
High:2.89
Open:2.89
Low:2.79
Close:2.84
Loading ...
Apr 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 16, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 22, 2021

Major Issues Report

8-K - Current report
Feb 18, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 09, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 08, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Major Issues Report

8-K - Current report
Feb 02, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 19, 2021

Major Issues Report

8-K - Current report
Dec 31, 2020

Major Issues Report

8-K - Current report
Dec 28, 2020

Major Issues Report

8-K - Current report